Poland· PL-100095799

Aknemycin Plus

A erythromycin, kombinationen product containing erythromycinum + tretinoinum, registered in Poland by Almirall Hermal GmbH. The same ATC class is registered in 6 of our 19 countries.

ATC D10AF52

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAknemycin PlusATCD10AF52REGISTER NO.PL-100095799PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Erythromycin, kombinationen is registered in 6 of 19 countries.

Countries holding a registration under ATC D10AF52 (erythromycin, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Erythromycin, kombinationen · ATC D10AF52

6 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Ireland
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Erythromycinum + Tretinoinum
Manufacturer
Almirall Hermal GmbH
Country
Poland (PL)
ATC code
D10AF52
ATC class
Erythromycin, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990815517

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Erythromycin, kombinationen in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythromycin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Czechia · Aknemycin Plus
  • Germany · Aknemycin Plus
  • France · Erylik
  • United Kingdom (Northern Ireland) · Aknemycin Plus
  • Greece · Acmefront, Erytin-Acn
  • Slovakia · Aknemycin Plus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/638dc9a4-4ae1-48e0-961f-218df76bb192
GET /v1/drugs/638dc9a4-4ae1-48e0-961f-218df76bb192?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Płyn na skórę",
  "source": "urpl",
  "strength": "(40 mg + 0,25 mg)/g",
  "packaging": "05909990815517 ¦ Rp ¦ 15960\n1 butelka 25 ml",
  "substance": "Erythromycinum 40 mg/g + Tretinoinum 0,25 mg/g",
  "common_name": "Erythromycinum + Tretinoinum",
  "pl_product_id": "100095799",
  "pozwolenie_nr": "08155",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about erythromycin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.